Red Wave Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$695K Buy
3,193
+232
+8% +$51.5K 0.21% 55
2025
Q4
$677K Hold
2,961
0.2% 55
2025
Q3
$686K Buy
2,961
+3
+0.1% +$611 0.21% 52
2025
Q2
$549K Hold
2,958
0.18% 58
2025
Q1
$620K Sell
2,958
-22
-0.7% -$4.28K 0.22% 53
2024
Q4
$530K Hold
2,980
0.19% 53
2024
Q3
$588K Sell
2,980
-14
-0.5% -$2.61K 0.21% 54
2024
Q2
$514K Sell
2,994
-41
-1% -$6.79K 0.19% 56
2024
Q1
$553K Buy
3,035
+17
+0.6% +$2.93K 0.21% 54
2023
Q4
$468K Buy
3,018
+8
+0.3% +$1.17K 0.18% 61
2023
Q3
$449K Sell
3,010
-1
-0% -$147 0.19% 61
2023
Q2
$406K Buy
3,011
+101
+3% +$14.8K 0.16% 65
2023
Q1
$464K Buy
2,910
+71
+3% +$10.9K 0.19% 56
2022
Q4
$459K Sell
2,839
-932
-25% -$143K 0.19% 54
2022
Q3
$506K Buy
3,771
+54
+1% +$7.75K 0.22% 52
2022
Q2
$569K Sell
3,717
-102
-3% -$15.6K 0.23% 50
2022
Q1
$619K Buy
3,819
+639
+20% +$92.8K 0.22% 54
2021
Q4
$431K Sell
3,180
-100
-3% -$11.8K 0.15% 59
2021
Q3
$354K Sell
3,280
-26
-0.8% -$2.97K 0.13% 64
2021
Q2
$372K Buy
3,306
+19
+0.6% +$2.14K 0.14% 60
2021
Q1
$356K Buy
3,287
+70
+2% +$7.49K 0.15% 60
2020
Q4
$345K Buy
+3,217
New +$309K 0.15% 55

Other funds holding ABBV

Red Wave Investments's ABBV Position: Q1 2026 in Review

Red Wave Investments increased its AbbVie (ABBV) stake by 7.8% in Q1 2026, buying an estimated $51.5K and bringing the position to 3,193 shares worth $695K. The position accounts for 0.21% of the portfolio, ranked #55.

Red Wave Investments first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Red Wave Investments held 3,193 shares of AbbVie worth $695K as of Q1 2026.
  • Red Wave Investments bought 232 AbbVie shares in Q1 2026, an estimated $51.5K.
  • AbbVie made up 0.21% of Red Wave Investments's portfolio in Q1 2026, its #55 holding.
  • Red Wave Investments first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Red Wave Investments's 13F filing for Q1 2026, filed 8 May 2026.